Following the revision of EU GMP Annex 1 for Sterile Medicinal product manufacturing, the PHSS: Pharmaceutical & Healthcare Society and PQG: Pharmaceutical Quality Group are joining together to host a discussion on revision with the regulatory authorities.
The revision of Annex 1 will impact all in sterile medicinal product manufacturing and those sectors where Annex 1 applies: Advanced therapies and Hospital pharmacy aseptic services.
The MHRA are invited to join discussion with the PHSS & PQG on the impact of Annex 1 revision and discuss focus group comments that are in preparation for submission to the EMA.
The impact of these changes will be discussed, book now to take part and add your comment!
For more info and registration visit: EU GMP Annex 1 Draft Revision Insight’ meeting